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Septicemia in dialysis patients: Incidence, risk factors, and regional and national data, epidemiologic studies within
prognosis. the United States indicate that infection is second to
Background. Infection is second to cardiovascular disease cardiovascular disease as the leading cause of death inas a cause of death in patients with end-stage renal disease
ESRD patients, occurring in approximately 12 to 22%(ESRD), and septicemia causes a majority of these infectious
of patients [1, 2]. Infections are also a leading cause ofdeaths. To identify patients at high risk and to characterize
modifiable risk factors for septicemia, we examined the inci- morbidity. They are responsible for a significant propor-
dence, risk factors, and prognosis for septicemia in a large, tion of hospital admissions and total hospital days for
representative group of U.S. dialysis patients. patients with ESRD [2].Methods. We conducted a longitudinal cohort study of inci-
One of the most serious and life threatening infectionsdent ESRD patients in the case-mix study of the U.S. Renal
Data System with seven years of follow-up from hospitalization in dialysis patients is septicemia. It accounts for over
and death records. Poisson regression was used to examine three fourths of deaths caused by infections [1]. Several
independent risk factors for hospital-managed septicemia. Cox clinical, treatment, and sociodemographic characteristics
proportional hazards analysis was used to assess the indepen-
make ESRD patients particularly susceptible to septice-dent effect of septicemia on all-cause mortality and on death
mia. Uremia often results in immune deficiency [3, 4].from septicemia. Separate analyses were performed for pa-
tients on peritoneal dialysis (PD) and hemodialysis (HD). Malnourishment and older age may interact with uremia
Results. Over seven years of follow-up, 11.7% of 4005 HD to impair the immune system further and to increase the
patients and 9.4% of 913 PD patients had at least one episode risk of infection in patients with ESRD [5]. Risk mayof septicemia. Older age and diabetes were independent risk
also vary according to the presence of comorbid condi-factors for septicemia in all patients. Among HD patients, low
tions such as diabetes mellitus (DM) and disruptionsserum albumin, temporary vascular access, and dialyzer reuse
were also associated with increased risk. Among PD patients, of dermal barriers to gain access for dialysis [6, 7]. In
white race and having no health insurance at dialysis initiation peritoneal dialysis (PD), infection may occur through
were also risk factors. Patients with septicemia had twice the
either the catheter entrance through the skin or the peri-risk of death from any cause and a fivefold to ninefold increased
toneal cavity [8]. In hemodialysis (HD) patients, infec-risk of death from septicemia.
Conclusions. Septicemia, which carries a marked increased tion may occur from the need for intravascular catheters
risk of death, occurs frequently in patients on PD as well as to perform dialysis [9, 10]. Infection may also depend
HD. Early referral to a nephrologist, improving nutrition, and on the type of vascular access used to conduct HD, reuseavoiding temporary vascular access may decrease the incidence
practices, and membrane selection [11–14].of septicemia. Further study of how race, insurance status, and
Despite these acknowledged pathophysiological pre-dialyzer reuse can contribute to the risk of septicemia among
ESRD patients is indicated. cepts, risk factors for septicemia have not been well
characterized in large, representative incident popula-
tions of dialysis patients in the United States. Recent
Infection is an important cause of mortality among studies of septicemia in prevalent dialysis patients may
patients with end-stage renal disease (ESRD). Using overlook risk factors that may be unique to the first few
months of dialysis and may also omit the highest risk
patients with relatively short survival on dialysis [15].Key words: end-stage renal disease, sepsis, hemodialysis, peritoneal
dialysis, infection, temporary vascular access, dialyzer reuse. Additionally, as the racial distribution and causes of
ESRD differ among nations, the risk for septicemiaReceived for publication June 1, 1998
among U.S. ESRD patients may differ from those re-and in revised form September 18, 1998
Accepted for publication September 19, 1998 ported in other populations. Furthermore, although sev-
eral studies have addressed risk factors for septicemia 1999 by the International Society of Nephrology
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among HD patients, few have addressed the risk of septi- eter) and reuse of dialyzers in each patient. We used
hospitalization records in the USRDS to assess hospitalcemia in PD patients and compared the risk factors for
sepsis in patients on PD and HD. Because prior reports admissions for septicemia over the seven-year follow-
up period. We used data from the U.S. Health Carehave shown that the percentage of deaths attributable
to infection are higher in PD-treated than in HD-treated Financing Administration (HCFA) 2746 death notifica-
tion form (date and cause of death) to assess survivalpatients [2], we conducted a study of septicemia in a large
population of incident U.S. dialysis patients in order to over the follow-up period [16].
define its incidence, risk factors, and natural history in
Construction of analytic variables andpatients on PD as well as HD. The relatively large sample
outcome measuressize and long period of follow-up of this study population
allowed for simultaneous adjustment of many potential The outcome variable was admission to the hospital
for septicemia. We defined this as patients having a pri-confounding variables, such as patient age, race, and
socioeconomic factors, that might influence the risk of mary International Classification of Diseases-9th Modi-
fication diagnosis code of 038.xx (septicemia) or 790.7sepsis in this population.
(bacteremia) on the discharge abstract. Because we were
interested in septicemia acquired in the outpatient set-
METHODS
ting, we limited the outcome variable to patients with a
Study design and patient population primary diagnosis code of septicemia. Thus, patients with
a secondary diagnosis of septicemia were excluded toWe conducted a national longitudinal cohort study of
the incidence, risk factors, and prognosis for hospitalized avoid including cases with hospital-acquired infection in
the definition of our outcome variable. We also requiredcases of septicemia in ESRD patients. We used baseline
data from a special case-mix study [16] of the U.S. Renal that repeat hospital admissions for septicemia be sepa-
rated by at least 30 days.Data System (USRDS) and follow-up data from hospi-
talization and death records in the USRDS. Patients Patient characteristics and treatment factors were
those obtained at the start of ESRD. Many of thesewere randomly selected for this study from the national
population of ESRD patients in the Medicare ESRD were relatively fixed or nonmodifiable (age, gender, race,
education, presence of DM), and some could vary overregistry using a two-stage cluster sampling procedure.
The criteria for selection were initiation of chronic main- time (serum albumin, hematocrit, treatment modality,
vascular access). Analyses examined the relationship oftenance dialysis for ESRD in 1986 or 1987, Medicare-
entitlement for dialysis services, no transplantation as these risk factors at baseline (onset of ESRD treatment)
to subsequent outcomes. To address the issue of changeinitial renal replacement therapy, and treatment at a
dialysis facility that was within one day of travel of the in baseline variables over the follow-up period, in se-
lected analyses, we assessed the relationship betweenESRD network office. To be eligible for this analysis,
we required patients to be age 18 years or older, of white risk factors and early (within the first 6 months of onset of
dialysis) versus late outcomes (after the first 6 months).or black race, and have a documented dialysis treatment
modality. Because 40% of patients undergoing HD had more
that one type of vascular access reported in the first six
Data collection weeks after the start of dialysis treatment, vascular access
was classified according to a hierarchy of perceived high-During 1991, abstractors from the ESRD Network
offices visited each dialysis facility and abstracted data est risk of septicemia (temporary catheter . permanent
central venous catheter . goretex or bovine graft .elements from the medical record into a standardized
form. The window for data collection was defined as the native fistula; Table 4). When two types of access were
reported, the patient was assigned the one with the high-period spanning from one month before to one month
after the patient’s first dialysis service in 1986 or 1987. est risk. For example, 507 patients who had both a tempo-
rary catheter and a native fistula in the baseline periodBaseline data collected include patient demographic in-
formation (age, gender, race), socioeconomic informa- were classified as having a temporary catheter, and 198
patients who had both a goretex or bovine graft and ation (for example, insurance status just before the start
of ESRD and education), laboratory data (for example, native arteriovenous fistula in the baseline period were
classified as having a goretex/bovine graft.serum albumin, hematocrit), comorbid disease (for ex-
ample, prior diagnosis of DM, neoplasm, congestive
Analysis of risk factors for septicemiaheart failure, peripheral vascular disease), and dialysis
modality (HD or PD). For HD patients, information was First, the crude rate of septicemia (episodes per 100
patient years) between HD patients and PD patientscollected on up to two types of vascular access in use
(native arteriovenous fistula, gortex graft, bovine graft, over the follow-up period was compared using the Wil-
coxon rank sum test. Then differences in the rate ofpermanent central venous catheter, and temporary cath-
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septicemia between HD and PD patients were examined RESULTS
in multivariate analyses (Poisson regression) adjusting Characteristics of patients
for age, gender, race, education, insurance status, region
Of the 5255 patients in the USRDS case-mix study,of the country (as defined by ESRD network), the pres-
4918 met the eligibility criteria: 186 patients who wereence of DM, serum albumin, hematocrit, and the pres-
neither black nor white race were excluded, as were 82ence of a neoplasm. All subsequent risk factor analyses
patients who were less than 18 years old or were notwere stratified by dialysis modality.
incident in 1986 or 1987. Sixty-nine patients had no docu-Second, the crude (or unadjusted) association between
mented dialysis treatment modality. Of the remainingpatient factors and the risk of septicemia over a seven-
patients, 4005 were HD patients and 913 were PD pa-year period following the initiation of dialysis was exam-
tients (Table 1). Hemodialysis patients were older andined using Poisson regression. Then, the independent
more likely to be black, whereas PD patients were moreassociation of each patient factor with hospital-managed
likely to be high school graduates. At the onset of ESRD,septicemia was examined, controlling for potential con-
PD patients were more likely to have DM, higher hema-founders, including age, gender, race, education, insur-
tocrit levels, and lower serum albumin levels than HDance status, region of the country, DM, serum albumin,
patients. Patients were represented from all areas of thehematocrit, and the presence of a neoplasm. Finally, the
United States. There were more PD patients in theindependent association of treatment factors (type of
Southeastern and Midwestern United States and morevascular access and reuse of dialyzers) with hospital-
HD patients in the Southwestern and Western Unitedmanaged septicemia was examined, controlling for the
States.potential confounders listed earlier here. Because vascu-
Nearly 40% of HD patients had more than one typelar access was ascertained at the initiation of dialysis,
of vascular access during the first six weeks of dialysis.the risk of septicemia within the first six months after the
Among those with only one type of vascular access,start of dialysis as well as at later periods was calculated.
24.4% had a native fistula, and 27.3% had a goretex orAlternative analyses modeling the risk of at least one
bovine graft. Dialysis membranes were reused in 57%episode of septicemia were done using logistic regression
of patients.with an adjustment for days at risk. Because the results
were robust across the different types of analyses, only Episodes of septicemia
the results from the Poisson regression are presented.
Over the seven-year period of follow-up, overall, 11%Selection of risk factors for septicemia was guided by
of patients (HD, 11.7%; PD, 9.4%) had at least oneour review of the literature and clinical knowledge. For
episode of septicemia that was managed in the hospital.completeness in the mortality analyses (discussed later
Most of these patients had only one episode of hospital-here), in addition to potential risk factors for survival
managed septicemia (Table 2). Although the rate of sep-in the ESRD population, such as age, DM, and serum
ticemia was always higher for HD patients than for PDalbumin, other important factors known to impact on
patients over the period of follow-up (Fig. 1), the differ-mortality in the general population were added, such as
ence was not statistically significant for any time period.cholesterol, smoking status, and the presence of cardio-
In addition, after controlling for age, gender, race, educa-vascular diseases.
tion, insurance status, DM, serum albumin level, and
hematocrit level using Poisson regression, there was still
Mortality analysis no difference in the rate of septicemia between HD pa-
tients and PD patients.To examine the prognosis of patients who developed
In HD patients, the following potential sources of in-septicemia, Kaplan-Meier survival analyses and Cox pro-
fection were listed as secondary diagnosis codes amongportional hazards analysis were used. The risk of death
all episodes of septicemia: infection/inflammation causedfrom all causes and from septicemia for patients who
by internal prostheses (18%), suggesting septicemia sec-had experienced an episode of septicemia was compared
ondary to vascular access infection, other complicationswith the risk of death for patients who did not have an
of internal prosthetic device (8%), decubitus ulcer (6%),episode of septicemia. In this analysis, we controlled for
urinary tract infections (5%), pneumonia (5%), gan-age, gender, race, education, insurance at onset of
grene (3%), endocarditis (2%), and cellulitis and abscessESRD, serum albumin, hematocrit, cholesterol, blood
of foot (1%), which is possibly related to diabetic periph-pressure at onset of ESRD, smoking status, and comor-
eral vascular disease. In PD patients, the potential infec-bid disease (presence of DM, congestive heart failure,
tious sources listed as secondary diagnosis codes wereneoplasm, left ventricular hypertrophy, coronary heart
infection/inflammation caused by internal prosthetic de-disease, cerebral vascular disease, and peripheral vascu-
vices or peritoneal catheter infection (12%), pneumonialar disease). All analyses were performed using the Sta-
tistical Analysis System [17]. (12%), peritonitis (5%), urinary tract infection (8%),
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Table 1. Characteristics of patients (N 5 4918)
Characteristic Hemodialysis Peritoneal dialysis P valueb
N 4005 913
Age (mean 6 sd) years 60.0 (15.9) 55.2 (16.5) ,0.0001
Female gender % 47.7 47.8 NS
Black race % 39.2 27.3 0.001
High school graduate % 56.1 65.7 0.001
No insurance prior to ESRD onset % 7.2 9.2 0.058
Diabetes mellitus %a 40.0 44.6 0.01
Serum albumin (mean 6 sd) g/dl 3.50 (0.54) 3.39 (0.56) ,0.0001
Hematocrit (mean 6 sd)% 26.1 (4.5) 28.2 (5.2) 0.0001
Access within 6 weeks of start of dialysis
temporary catheter % 4.9 —
permanent catheter % 4.9 —
goretex or bovine graft % 27.3 —
native AV fistula % 24.4 —
more than one % 38.4 —
Dialyzer reuse % 57.0 —
Geography of treatment facility [Network]
Northeast [1–5] % 37.1 35.7 NS
Northeast [6–8] % 18.2 27.8 0.001
Mideast [9–12] % 20.4 24.0 0.018
Southwest [13–15] % 12.3 7.1 0.001
West [16–18] % 11.9 5.4 0.001
a Represents diabetes mellitus as a comorbid condition, not diabetes mellitus as the cause of ESRD; NS 5 not significant P $ 0.05
b t-test for continuous variables (age, serum albumin, hematocrit); x2 for categorical values
Table 2. Episodes of hospital managed septicemia during the seven Among PD patients, the risk was twofold. Hemodialysis
year follow-up period in patients with onset of ESRD treatment
patients with a serum albumin level of less than 3.5 mg/in 1986–1987
dl had a 66% higher risk of hospital-managed septicemia
Number of episodes of Hemodialysis Peritoneal dialysis than patients with higher albumin levels. Female gender,septicemia per person N 5 4005 N 5 913
educational status, hematocrit level, and the presence of
None % 88.3 90.6
cancer were not associated in this analysis with hospital-One % 9.7 8.8
Two % 1.5 0.7 managed septicemia.
Three or more % 0.4 0
Treatment factors associated with septicemia
Type of vascular access. Table 4 shows that over the
entire period of follow-up, HD patients with a temporaryendocarditis (2%), and cellulitis and abscess of foot
catheter had a 50% higher risk of septicemia than pa-(2%).
tients with a native fistula. Patients with a gortex or
bovine graft had a 33% higher risk of septicemia thanPatient characteristics associated with septicemia
patients with a native fistula during the entire seven yearsIn both HD and PD patients, crude and adjusted analy-
of follow-up. During the first six months after the onset ofses indicated that older age was associated with a 60 to
ESRD, patients with permanent central venous catheters90% higher risk of hospital-managed septicemia (Table
also had an increased risk of septicemia compared with3). Black PD patients had a lower risk of septicemia
patients with native fistulae.than did white PD patients. For HD patients, the point
Reuse of dialyzers. We assessed the relationship be-estimate suggested a lower risk of septicemia in black
tween reuse of dialysis membranes in individual patientsversus white patients; however, the result was not statisti-
undergoing HD and the risk of septicemia. Patients whocally significant.
reused dialyzers had a 28% higher risk of septicemiaWhen compared with PD patients with private insur-
than patients who did not reuse membranes over theance at baseline, uninsured PD patients and those with
entire follow-up period.Medicaid insurance at the onset of ESRD were at greater
risk of septicemia. However, the association of insurance
Prognosis of patients with septicemiastatus and increased risk of septicemia did not hold for
We examined the natural history of patients who hadHD patients.
experienced an episode of septicemia (Table 5). In theIn both unadjusted and adjusted analyses, the presence
Cox proportional hazards model analyses, both HD andof DM was associated with a higher risk of hospital-
managed septicemia in both HD and PD patients. PD patients who experienced an episode of hospital-
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Fig. 1. Episodes of septicemia per 100 pa-
tient-years at risk differing follow-up time pe-
riods after dialysis initiation. Symbols are: ( )
hemodialysis patients; ( ) peritoneal dialysis
patients. Upper and lower limits of the boxes
at each time point represent 95% confidence
intervals, and (2) represents the point esti-
mate.
managed septicemia had more than a twofold higher rate we observed for patients on HD for more than 36
months was comparable to that recently reported byrisk of death from any cause than patients who had not
Hoen et al in their study of septicemia in prevalent HDexperienced an episode of hospital-managed septicemia.
patients in France [15]. Although many reports haveThis effect persisted even after adjusting for age, gender,
described rates for exit-site infections and peritonitis forrace, education, insurance at the onset of ESRD, serum
patients on PD, to our knowledge, few have addressedalbumin, hematocrit, cholesterol, blood pressure at the
the incidence of septicemia in patients on PD, which weonset of ESRD, smoking status, and comorbid disease
found to be comparable to that of patients on HD.(presence of DM, congestive heart failure, neoplasm,
and peripheral vascular disease). Hemodialysis patients
Age and diabetes as risk factors for septicemiawho experienced an episode of hospital-managed septi-
Our study documents that, as one might expect, oldercemia had a ninefold greater risk of death from septice-
patients and patients with diabetes, who made up 40%mia than patients who had not experienced an episode
of the incident ESRD population in the case-mix study,of hospital-managed septicemia after adjustment. Al-
are at increased risk of septicemia, regardless of dialysisthough the risk of death from septicemia for PD patients
modality. Diabetes is well known as a general risk factorwas also high following an episode of septicemia, it was
for infection because of impaired immunologic defensealmost half of that for HD patients, after adjustment for
mechanisms and deficient phagocytic function, which hascase mix.
been observed in diabetics with poor metabolic control
[6]. Combined with the impaired immune defenses in
DISCUSSION uremia, the increased risk in this patient group should
This national study of incident U.S. ESRD patients alert clinicians to be vigilant for signs of infection.
demonstrates that septicemia, which requires hospital In contrast to our findings, in the EPIBACDIAL
admission, is a common event for both HD and PD Study, which focused on determining risk factors for
patients, occurring in more than 10% of patients over bacteremic in chronic HD patients, Hoen et al did not
seven years of follow-up. Few medical conditions, except find age and DM to be independent risk factors for septi-
for chemotherapy-induced neutropenia, immunosup- cemia [15]. The difference between the results of these
pression, and intravenous drug abuse, are associated with two studies could be related to differences in sample size
higher rates of septicemia than those we observed for and case mix. The number of patients studied in the
dialysis patients in this national study. Our findings on EPIBACDIAL study was smaller than the U.S. popula-
the incidence of septicemia in U.S. HD patients with tion we studied. In their multivariate analyses, Hoen et
ESRD is comparable to that reported by Churchill et al al studied only 44 episodes of bacteremia in 865 patients,
whereas we studied 559 episodes in 4918 patients. Fur-in the Canadian Hemodialysis Morbidity Study [18]. The
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Table 3. Association between patient factors and septicemia episodes in dialysis patients
Hemodialysis patients Peritoneal dialysis patients
Unadjusted Adjusteda Unadjusted Adusteda
Characteristic risk ratio risk ratio risk ratio risk ratio
Age . 65 years 1.75(1.48–2.06)b 1.61(1.35–1.92)b 1.63(1.06–2.50)b 1.90(1.17–3.08)b
Female gender 1.09(0.92–1.28) 0.96(0.81–1.14) 1.26(0.84–1.90) 1.17(0.77–1.79)
Black race 0.83(0.70–0.97)b 0.91(0.76–1.08) 0.56(0.34–0.90)b 0.53(0.31–0.90)b
High school grad 1.12(0.90–1.40) 1.20(0.95–1.50) 0.72(0.42–1.25) 0.82(0.46–1.45)
Insurance status:
None 0.66(0.46–0.96)b 0.89(0.61–1.32) 1.59(0.90–2.81) 2.69(1.43–5.05)b
Medicaid 1.01(0.82–1.24) 1.00(0.80–1.25) 1.27(0.73–2.21) 1.83(1.00–3.36)b
Medicare or private insurance 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Diabetes mellitus 1.28(1.08–1.51)b 1.26(1.06–1.50)b 1.92(1.28–2.90)b 2.21(1.43–3.40)b
Serum albumin , 3.5 g/dl 1.79(1.50–2.14)b 1.66(1.38–1.99)b 1.44(0.93–2.23) 1.22(0.77–1.91)
Hematocrit .25% 0.93(0.78–1.12) 0.92(0.77–1.11) 0.86(0.53–1.40) 0.66(0.40–1.11)
a Adjusted for age, gender, race, education, insurance status, diabetes, serum albumin, hematocrit, neoplasm and geographic location, except for the characteristic
of interest, using Poisson regression. For the hemodialysis population, also adjusted for vascular access and reuse of dialyzers
b P , 0.05
Table 4. Association between treatment factors and septicemia episodes in hemodialysis patients
Entire follow-up period Early (first 6 months after Late (after 6 months or more
(up to 7 years) start of dialysis) after start of dialysis)
Treatment factor Adjusteda RR(95% CI)
Type of vascular access (first 6
weeks after start of dialysis
treatmentb
Temporary catheter 1.48 (1.16–1.89)c 2.26 (1.15–4.46)c 1.37 (1.06–1.78)c
Permanent subclavian catheter 1.35 (0.95–1.92) 2.38 (0.997–5.66) 1.22 (0.82–1.80)
Goretex or bovine graft 1.34 (1.04–1.71)c 1.63 (0.79–3.38) 1.29 (0.99–1.69)
Native fistula 1.00 (reference) 1.00 (reference) 1.00 (reference)
Reuse of dialysis membranes 1.28 (1.05–1.56)c 1.40 (0.87–2.25) 1.23 (0.99–1.53)
RR is risk ratio.
a Adjusted for age, gender, race, education, insurance status, diabetes, serum albumin, hematocrit, geographical location and neoplasm using Poisson regression
b For patients who had more than one type of vascular access, access was classified as the one with the presumed higher risk, (that is, temporary catheter
(33.7%) . permanent central venous catheter (9.1%) . goretex or bovine graft (32.9%) . native arteriovenous fistula (24.4%)
c P , 0.05
thermore, only 12% of the population of the EPIBAC- as a categorical variable (an age of more than 65 years),
rather than as a continuous variable, as was done in theDIAL study were diabetic compared with more than
40% of our U.S. population. Our study therefore had EPIBACDIAL study. This finding is in accordance with
previous knowledge that the function of the immunegreater power to detect an increased risk of septicemia
among diabetics. Although a statistically significant in- system declines with age, putting the older population
at greater susceptibility to infections [20, 21].creased risk of septicemia in diabetics was not observed
in the EPIBACDIAL study, more than 7% of their pa-
Effect of hematocrit on risk of sepsistients with DM had an episode of septicemia with an
increased relative risk of 1.63. Other studies corroborate Although the EPIBACDIAL study suggested a pro-
our evidence of an association between DM and septice- tective effect of an increased hematocrit against septice-
mia in dialysis patients. In another French prospective mia, we did not find a significant protective effect against
septicemia associated with an increase in hematocrit.study, Roubicek et al found that diabetic HD patients
were at significantly higher risk of bacteremia than non- This difference may be related to the populations studied,
differences in the measurement of anemia, and the impactdiabetic patients [19].
Although Hoen et al did not find a statistically signifi- of recombinant human erythropoietin (rHuEPO). The
EPIBACDIAL study reported that an increase of 1 g/dlcant increased risk of sepsis with increased age, patients
with bacteremia in their study were older than those hemoglobin was associated with protection against bac-
teremia. Although the point estimate for the relativewho did not experience bacteremia, and this approached
statistical significance. We found a statistically significant risk in our analysis did suggest a protective effect for a
hematocrit of more than 25% against risk of septicemia,association between age and sepsis when we used age
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Table 5. Association of septicemia with death
Hemodialysis patients Peritoneal dialysis patients
risk ratio (95% CI) risk ratio (95% CI)
Type of death Unadjusted Adjusteda Unadjusted Adjusteda
Death from all causes 2.74 (2.44–3.07)b 2.40 (2.12–2.72)b 2.66 (2.02–3.50)b 1.73 (1.23–2.44)b
Death from septicemia 9.62 (6.75–13.73)b 9.79 (6.49–14.76)b 7.25 (3.40–15.48)b 4.81 (1.56–14.81)b
Death from other causes 2.44 (2.16–2.76)b 2.14 (1.87–2.45)b 2.46 (1.82–3.32)b 1.77 (1.23–2.55)b
a Adjusted for age, gender, race, diabetes mellitus, serum albumin, hematocrit, education, insurance at onset of ESRD, cholesterol, blood pressure, smoking,
obesity and comorbid disease (neoplasm, congestive heart failure, LVH, coronary disease, cerebrovascular disease and peripheral vascular disease). Septicemia is
modeled as a time dependent covariate
b P , 0.01
the association was not statistically significant. The rea- patients, low serum albumin and vascular grafts rather
sons for this difference are not completely clear. The than native fistulae conferred increased risk for septice-
study populations differed in their baseline hematocrit mia. Although the estimate of risk for sepsis associated
levels. At the time when the patients were enrolled in with permanent central venous catheters was twice that
the case-mix study, rHuEPO was not available. This is of patients with native fistulae in the first six months
in contrast to the EPIBACDIAL study, in which over after dialysis initiation in our study, we did not see the
half of the study participants were receiving rHuEPO. marked sevenfold increased risk of septicemia associated
The use of rHuEPO has dramatically reduced the sever- with permanent central venous catheters recently re-
ity of anemia and the need for blood transfusions in ported by Hoen et al in the EPIBACDIAL study [15].
dialysis patients. It has also been associated with a fall The difference between our estimate of permanent cen-
in serum ferritin levels, suggesting that a reversal of tral venous catheter risk and the estimate from the EPI-
secondary hemosiderosis may be the mechanism through BACDIAL study may be due to our examining incident
which the frequency of bacterial infection decreases in dialysis patients who frequently had temporary access,
HD patients on rHuEPO. Although in our study we do whereas the EPIBACDIAL study included prevalent
not have data on ferritin levels, in vitro studies suggest patients, with an average five-year duration of ESRD.
that iron overload may increase the dialysis patient’s Patient demographic differences and differences in prac-
susceptibility to infection by two mechanisms. The first tice patterns between the United States and France may
mechanism is the enhancement of bacterial growth in also play a role.
an iron-enriched medium. The second mechanism is im- In this incident ESRD patient group, we observed a
pairment of phagocytic function [22, 23]. Several authors 50% increased risk of septicemia associated with tempo-
have shown an increased risk of septicemia in HD pa- rary catheters for vascular access compared with native
tients with a serum ferritin level above 1,000 mg/liter [24, fistulae. The higher risk may be inherent to the tempo-
25]. EPIBACDIAL study patients are likely to have rary catheter or may be confounded by the type of pa-
had higher hematocrits, lower serum ferritin, and fewer tient who would need a temporary catheter at first dial-
blood transfusions than patients in our analysis. Few
ysis. Having a surgically created graft or native fistula
patients in the case-mix study (pre-rHuEPO) had hema-
for HD access within six weeks of initiation of dialysistocrits of more than 25%, and those that did most likely
suggests a patient with long-term medical involvementreceived frequent blood transfusions. It is possible that
prior to ESRD. This involvement may confer a protec-we did not see a protective effect associated with in-
tive effect against septicemia. Of note, our analysis ofcreased hematocrit because of the possible confounding
vascular access risk was complicated by the large numbereffect of elevated serum ferritin levels, which were un-
of patients who had more than one access when baselinemeasured in our analysis. Further suggestive evidence
data collection occurred. Additionally, calculating theof the potential benefits of rHuEPO and increased hema-
risk of a particular access type with risk of septicemiatocrit in dialysis patients, consistent with the finding in
at time points distant from when the access informationthe EPIBACDIAL study, has recently been presented
was obtained is limited by the potential for misclassifica-by Collins, Ma and Ebben in work demonstrating that
tion.hospital length of stay and the risk of hospitalization in
Low serum albumin. Among HD patients, low serumgeneral significantly decrease as patients’ hematocrits
albumin at baseline was also an identifiable risk factorincrease [26, 27].
for septicemia. Low serum albumin may represent nutri-
Risk factors for septicemia in hemodialysis patients tional deficiency in dialysis patients and has previously
been shown to be a strong predictive risk factor forVascular access. As in the Canadian Hemodialysis
Morbidity Study [18], we found that among U.S. HD death [28, 29]. Our findings suggest that prevention and
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treatment of dialysis associated malnutrition through nu- Bloembergen et al found an increased risk of death from
infection in white females and in white patients withtritional counseling, avoiding low-protein diet months
before implementation of renal replacement therapy, diabetes [2, 37]. The explanation for a lower risk of
septicemia in black PD patients remains unclear. Possi-and increasing the dose of dialysis to improve appetite
and correct acidosis may eventually decrease the risk of ble explanations include selection bias, as only healthier
black patients may be selected for PD. Also, white pa-septicemia in this vulnerable population.
Membrane reuse. Among HD patients, membrane re- tients may more readily go on to transplant, leaving
“sicker” whites and relatively “healthier” blacks on dial-use was also an independent risk factor for septicemia
in this analysis. One of the major concerns with dialyzer ysis [16].
In examining possible socioeconomic factors that mayreuse is the risk of infection. Recently, several case re-
ports in the medical literature have cited an association increase risk of septicemia, we found that among PD
patients, having no insurance prior to the onset of ESRDbetween reuse and individual patient’s infections [30–
33], but there have been no large representative cohort is a strong marker for septicemia. We found an apparent
stepwise increase in risk of septicemia for patients withstudies linking reuse with the risk of septicemia. Reuse
has been associated with lower survival among HD pa- Medicare or private insurance at baseline (reference) to
those covered by Medicaid (RR 1.83), to patients withtients in prior studies [12, 14], but the reasons for this
increased mortality have not been clear. Although it has no insurance at baseline (RR 2.69). This finding could
be explained if patients without insurance present forbeen proposed that infectious causes of death might be
more common if reused dialyzers were improperly disin- dialysis services with more advanced renal disease and
have already suffered adverse effects from long-standingfected, the mortality risks associated with reuse are re-
portedly similarly elevated for infectious, cardiovascular, uremia, hypertension, and hyperparathyroidism due to
limited access to health care.and other causes of death [14]. Our finding of an associa-
tion of reuse and septicemia again raises the possibility
Limitationsthat decreased survival with some types of reuse may be
mediated through infection. Recently, Collins et al also In interpreting the risk factors for sepsis enumerated
in this study, it is important to note that we examinedreported on the effect of reuse of dialyzers on survival
of HD patients at free-standing facilities. They found only hospital-managed septicemia listed as the primary
International Classification of Diseases-9th Modificationthat for patients who entered HD in 1991 to 1993, there
was no association between the reuse germicide used code for a hospital admission. Certainly, some cases of
bacteremia may be managed on an outpatient basis, andand survival, but patients who entered HD in 1988 to
1990 had a higher risk of death with peracetic acid [34, others may be reported as secondary diagnoses. We
therefore analyzed for risk of more severe cases of septi-35]. Because patients in the case-mix study were incident
in 1986, they may be more similar to the earlier cohort cemia, or cases more likely to be hospitalized, possibly
underestimating the frequency of disease in both HDin Collins et al’s analysis. This suggests that potential
changes in reuse practices over time could explain the and PD patients. Furthermore, the management of “bac-
teremia” may differ significantly between HD patients,variability in risk associated with reuse between our
study and other studies in different time periods. Further who have ready vascular access and might be cultured
and treated at outpatient HD, and PD patients, who doanalyses of potential interactions between secular trends
in reuse of dialyzers and risk of infection-related morbid- not have vascular access and are less frequently seen on
a routine outpatient basis by medical personnel.ity, including septicemia, are warranted.
A second limitation of our study is that most patient
Risk factors for septicemia among PD patients. and treatment factors assessed as potential risk factors
were ascertained at the initiation of dialysis. For non-Risk factors for hospital-managed septicemia and its
outcome among U.S. PD patients have not been pre- modifiable characteristics such as age, gender, and race,
this is not a limitation. However, for patient factors thatviously reported. We found that in U.S. PD patients,
white race is a risk factor for septicemia even after taking may change over time, such as vascular access, insurance
status, serum albumin, hematocrit, and even dialysisinto account other factors, including health insurance
and education. Although a racial difference was also modality, assessing the risk of septicemia several years
after these data were obtained may lead to misclassifica-suggested among HD patients, the protective effect of
black race against sepsis was not statistically significant tion and may bias our results. Because data in our analy-
sis were abstracted from a single chart review, there wasin the adjusted analysis. The association of increased risk
for sepsis for white PD patients is the opposite of that no opportunity to track individual changes in albumin,
hematocrit, or vascular access over time. Therefore, toseen in the general population [36], but analogous racial
differences have been described previously in ESRD. In address the changes in the laboratory values or vascular
access over the follow-up period, we assessed the rela-comparing causes of death in dialysis patients by race,
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tionship between risk factors for septicemia within the outlined for septicemia are older age, diabetes, low se-
rum albumin, temporary vascular access, and reuse, andfirst six months after the start of dialysis as well as later
periods. We found that the results were unchanged also in PD patients, white race and no insurance, which
are factors that identify a particularly vulnerable groupacross the different time periods. Insurance status is an-
other baseline variable that changes over time, as almost of patients with ESRD. Several of the risk factors identi-
fied in this study are modifiable risk factors (for example,all patients with ESRD become eligible for Medicare.
Our analysis of risk during the first six months of treated serum albumin, temporary vascular access). Early refer-
ral to a nephrologist, as emphasized in recent DialysisESRD would most closely approximate the risk of the
individual who was uninsured prior to dialysis. Outcomes Quality Initiative guidelines, might help ame-
liorate the risk of septicemia, by improving the nutri-For the issue of reuse, we examined only whether an
individual patient reused dialyzers for HD. We did not tional status of the patients, correcting the anemia of
chronic renal failure by starting rHuEPO even beforehave access to information on the type of disinfectant
process used prior to reuse. In prior studies, increased dialysis when necessary, assisting with better insurance
coverage before dialysis, and more importantly, minimiz-risk of mortality has been suggested with only certain
reuse practices. As this information was not available in ing use of temporary catheters at the start of dialysis by
insertion of permanent fistula in the pre-ESRD periodthe current study, we are unable to relate our findings of
increased risk of septicemia with any particular dialyzer [40, 41]. Further analyses to elucidate potential mecha-
nisms for variations in risk for septicemia according todisinfectant or reuse process [14].
A potential weakness of our analysis of mortality race, access to health insurance, and dialyzer reuse prac-
tices over time are warranted.caused by septicemia is our necessary reliance on HCFA
form 2746 for cause of death. Standard death certificate
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